Moramide intermediate
 | |
| Systematic (IUPAC) name | |
|---|---|
|
3-Methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid | |
| Clinical data | |
| Routes of administration | N/A |
| Legal status |
|
| Identifiers | |
| CAS Number | 3626-55-9 |
| ATC code | none |
| PubChem | CID 567581 |
| ChemSpider | 493453 |
| Synonyms | moramide intermediate |
| Chemical data | |
| Formula | C21H25NO3 |
| Molar mass | 339.4281 g/mol |
| |
| |
Moramide intermediate (3-methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.
In the United States, moramide intermediate is designated as a Schedule II controlled substance,[1] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[2]
See also
- Moramide
- Methadone intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
References
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.